Dublin, April 24, 2026 (GLOBE NEWSWIRE) — The “AI-Based Clinical Trial Solution Providers Market Report 2026” has been added to ResearchAndMarkets.com’s offering.
The AI-based clinical trial solution providers market is experiencing unprecedented growth, projected to expand from $3.03 billion in 2025 to $3.72 billion in 2026, with a CAGR of 22.9%. Key factors of this historic growth include traditional patient recruitment methods, high costs of conventional monitoring, and fragmented trial oversight.
Looking ahead, the market is set to reach $8.53 billion by 2030, driven by advancements in AI algorithms, cloud-based platforms, and decentralized trial infrastructures, boasting a CAGR of 23%. Significant trends anticipate an increased use of AI for recruitment optimization and integration of real-world evidence, with a surge in demand for regulatory compliance automation.
AI adoption is pivotal in transforming clinical trial solutions, improving recruitment, enhancing trial predictions, and enabling real-time safety monitoring. A report by the United States Census Bureau in March 2024 highlights rapid AI adoption, impacting market growth significantly.
Leading companies in this sector are innovating with AI-driven data platforms to strengthen their market positions. For instance, Saama Technologies launched an AI data platform centralizing clinical trial data, which automates tasks and delivers real-time insights into operations and patient information.
In corporate movements, Florence Healthcare’s acquisition of VersaTrial Inc. in September 2023 reflects strategic expansions and collaborations to enhance service offerings for research sites and sponsors.
Prominent industry players include International Business Machines Corporation, IQVIA Holdings Inc., Saama Technologies Inc., Deep 6 AI Inc., and PathAI Inc., among others, driving technological innovation and market growth.
Regionally, North America held the largest market share in 2025, while Asia Pacific is expected to grow the fastest during the forecast period. This growth is across regions like Western Europe, Eastern Europe, North America, and others, including countries such as the USA, China, India, and Germany.
Tariffs have impacted the market, particularly affecting imports of AI software platforms and advanced tools, which led to increased operational costs. However, they have also spurred local software development and innovation.
The market research report delivers a comprehensive overview of key market statistics, insights into major trends, and opportunities. It encompasses analysis of market size, regional shares, competition, and trends, offering valuable information for thriving in the industry.
AI-based clinical trial solutions are pivotal for improving accuracy and efficiency across phases including I, II, and III, especially in therapeutic areas like oncology and cardiovascular diseases. The market supports pharmaceutical companies, academic institutions, and beyond, fueling a transformative shift in clinical trial processes.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026 – 2030 |
| Estimated Market Value (USD) in 2026 | $3.72 Billion |
| Forecasted Market Value (USD) by 2030 | $8.53 Billion |
| Compound Annual Growth Rate | 23.0% |
| Regions Covered | Global |
Key Technologies & Future Trends
- Artificial Intelligence & Autonomous Intelligence
- Digitalization, Cloud, Big Data & Cybersecurity
- Industry 4.0 & Intelligent Manufacturing
- Biotechnology, Genomics & Precision Medicine
- Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
- Increasing Use of AI for Patient Recruitment Optimization
- Rising Adoption of AI-Driven Data Analytics in Clinical Trials
- Expansion of Virtual and Decentralized Clinical Trials
- Integration of Real-World Evidence and Predictive Modeling
- Growing Demand for Regulatory Compliance Automation
Companies Featured
- International Business Machines Corporation
- IQVIA Holdings Inc.
- Saama Technologies Inc.
- AiCure LLC
- Deep 6 AI Inc.
- DEEP LENS AI Inc.
- Unlearn.AI Inc.
- Intelligencia Inc.
- Median Technologies SAS
- PathAI Inc.
- Koneksa Health Inc.
- GNS Healthcare Inc.
- CytoReason
- Ardigen
- BenevolentAI SA
- Exscientia
- Mendel Health Inc.
- Concentro Health AI
- Antidote Technologies Inc.
- TriNetX Inc.
- Phesi
For more information about this report visit https://www.researchandmarkets.com/r/k2ziy2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- AI-Based Clinical Trial Solution Providers Market
